Tamar Howson

Tamar Howson

Director/Board Member at IMMUNIC, INC.

Net worth: - $ as of 30/05/2026

77 year
Health Technology
Finance
Consumer Services

Profile

Ms. Tamar D.
Howson
is an Independent Director at Immunic, Inc. She is on the Board of Directors at Immunic, Inc., Organovo, Inc. and Immunic AG.
Ms. Howson was previously employed as an Independent Director by Cue Biopharma, Inc., an Independent Non-Executive Director by MEI Pharma, Inc., an Independent Director by ContraVir Pharmaceuticals, Inc., an Independent Director by Enzymotec Ltd., an Independent Director by Cynapsus Therapeutics, Inc., an Independent Director by Cardax, Inc., an Independent Director by Organovo Holdings, Inc., an Independent Director by Soligenix, Inc., an Independent Director by Mateon Therapeutics, Inc., an Independent Director by Idenix Pharmaceuticals LLC, an Independent Director by Allergan Ltd. (Ireland), an Independent Director by Aradigm Corp., a Principal by Howson Associates Ltd., a Member by JSB-Partners LP, an Executive Vice President-Corporate Development by Lexicon Pharmaceuticals, Inc., a Senior VP-Corporate & Business Development by Bristol Myers Squibb Co., a Senior VP & Director-Business Development by Smithkline Beecham Plc, a Senior VP & Director-Business Development by GlaxoSmithKline Plc, a Vice President-Venture Investments by Johnston Associates, Inc., a Director-Worldwide Business Development by Squibb Corp., and a Chief Executive Officer & Director by S*BIO Pte Ltd. She also served on the board at Cardax Pharmaceuticals, Inc., Warner Chilcott Plc, Worldwide Business Development Corp., Actavis Pharma, Inc., ARIAD Pharmaceuticals, Inc., BioLineRx Ltd., HBA Corp., Healthcare Businesswomens Association, International Partnership for Microbicides, NPS Pharmaceuticals, Inc., Pacira Pharmaceuticals, Inc. (California), Scientus Pharma, Inc., SkyePharma Plc and Targacept, Inc. She received her undergraduate degree from Technion-Israel Institute of Technology, a graduate degree from The City College of New York and an MBA from The Trustees of Columbia University in The City of New York.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/05/2026 0 ( -.--% ) - $ 30/05/2026

Tamar Howson active positions

CompaniesPositionStart
IMMUNIC, INC. Director/Board Member 10/10/2019
Director/Board Member -
Director/Board Member -

Former positions of Tamar Howson

CompaniesPositionEnd
LITE STRATEGY, INC. Director/Board Member 30/10/2023
CUE BIOPHARMA, INC. Director/Board Member 06/06/2023
Director/Board Member 30/11/2019
VIVOSIM LABS, INC. Director/Board Member 04/09/2019
HEPION PHARMACEUTICALS, INC. Director/Board Member 17/10/2018
See the detail of Tamar Howson's experience

Training of Tamar Howson

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

77

1st degree connections

41

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies41

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Health Services

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Retail Trade

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Health Technology

Health Technology

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Process Industries

Howson Associates Ltd.

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!